Abstract
Background -The purpose of this study was to assess the causes of communityacquired pneumonia in adult patients admitted to hospital. Methods -A prospective study was performed on 346 consecutive adult patients (54% men) of mean (SD) 49 3 (19.5 ) years (range 17-94) admitted to a university affiliated regional hospital in southern Israel with community-acquired pneumonia over a period of one year. Convalescent serum samples were obtained from 308 patients (89%). The aetiological diagnosis for community-acquired pneumonia was based on positive blood cultures and/or significant changes in antibody titres to Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, respiratory viruses, Coxiella burnetii, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella sp. Results -The aetiology of communityacquired pneumonia was identified in 279 patients (80.6%). The distribution of causal agents was as foliows: S pneumoniae, 148 patients (42-8%); M pneumoniae, 101 (29.2%); C pneumoniae, 62 (17-9%); Legionella sp, 56 (16.2%); respiratory viruses, 35 (10-1%); C burnetii, 20 (5.8%); H influenzae 19 (5 5%); and other causes, 21 patients (6-0%). In patients above the age of 55 years C pneumoniae was the second most frequent aetiological agent (25-5%). In 133 patients (38.4%) more than one causal agent was found. Conclusions -The causal agents for community-acquired pneumonia in Israel are different from those described in other parts of the world. In many of the patients more than one causal agent was found. In all these patients treatment should include a macrolide antibiotic, at least in the first stage of their illness.
(Thorax 1996;51:179-184)
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Community-acquired pneumonia is a common and important cause of admission to hospital, and presents a challenge to physicians who must decide upon specific therapy without the benefit of a definitve aetiological diagnosis. In order to reach logical therapeutic decisions physicians need reliable data on the relative prevalence of different aetiological agents in the patient's area ofresidence, in addition to the clinical, laboratory, and radiological findings. The We have conducted a prospective study of the prevalence of causal agents in all adult patients admitted with community-acquired pneumonia during one year to the Soroka Medical Center in Beer-Sheva, Israel. In order to make the best use of advanced serological laboratory techniques, a concerted effort was made to obtain convalescent serum samples from most of the patients.
The Soroka Medical Center in Beer-Sheva is located in a city of 150 000 residents in the south ofIsrael. It serves a population of 300 000 inhabitants of the Negev region, a semi-arid desert area mostly at sea level. Average temperatures during the study year ranged from 27°C in the summer to 9°C in the winter. The average yearly rainfall (which falls exclusively during the winter) is 200 mm.
Methods

PATIENTS
A prospective study of the causes of community-acquired pneumonia was conducted in 346 adult patients admitted between 1 November 1991 and 31 October 1992. The study was approved by the review board for human research (the Helsinki committee) of the Soroka Medical Center and all patients gave their informed consent to participate.
The mean (SD) age of the patients was 49-3 (19-5) years (range 17-94). One hundred and eighty seven patients (54%) were men. Sixteen patients (4'6%) died in hospital. All other patients were alive at least six weeks after admission. During the course of their hospital stay the patients were diagnosed and treated by the medical staff of the internal medicine wards without intervention by the investigators. At discharge the patients were referred to the investigators at the outpatient clinic of the hospital for follow-up.
Community-acquired pneumonia was considered to be present by an acute febrile illness with a new pulmonary infiltrate on the chest radiograph, and a clinical and radiological course that confirmed the diagnosis. Exclusion criteria included a positive blood test for HIV, lung malignancy and patients who had been discharged from hospital within the preceding 21 days.
SERUM SAMPLES
In addition to routine hospital blood tests, a serum sample was obtained within the first 48 hours of admission for serological testing. A second (convalescent) serum sample was obtained from 308 patients (89%) usually at the follow up appointment. The mean interval between the two serum samples was 31- Community-acquired pneumonia was considered to be caused by S pneumoniae if there was a positive culture for S pneumoniae (blood or pleural fluid) or a positive serological diagnosis based on pneumolysin antibodies or the presence of S pneumoniae specific immune complexes as detailed above; it was considered to be due to H influenzae or M catarrhalis in the presence of a positive blood culture or positive serology. M pneumoniae was diagnosed as the causal agent by two different serological methods using commercial kits. Both tests were performed on all 654 serum samples. The antibody titre was determined by microparticle agglutination using the commercial kit SerodiaMyco II (Fujirebio, Japan). Using this method, M pneumoniae was diagnosed if there was a fourfold increase in antibodies in the paired serum samples and/or an antibody titre of at least 1:160 in at least one serum sample."
The antibody titre for M pneumoniae was also determined by the antibody capture enzyme immunoassay method using the commercial kit Sero M pneumoniae test kit (Diatech Diagnostics, Israel). In this method M pneumoniae was diagnosed if IgM antibodies were present in at least one serum sample, or if there was evidence of seroconversion or a significant increase in IgG, IgM, or IgA between the two serum samples. M Table 2 shows the distribution of causes among the 346 patients. A single agent was found in 146 patients (42-2% of all patients and 52-3% of patients with a causal diagnosis), while 2-6 agents were found in 133 patients (38&4% and 47-7%, respectively). Table 3 presents the rate of association between the different causal agents in patients with mixed infection, with the numbers and percentages of patients with single agents. All possible associations were found except for agents with particularly low frequencies.
Discussion
Our study is unique in several ways. The study population is one of the largest published' and reflects a complete picture of all the causes of community-acquired pneumonia in adult patients admitted to a hospital in one region, covering all the seasons of the year. Our success in obtaining convalescent serum sample from 89% of the patients enabled us to establish a causal diagnosis for community-acquired pneumonia in 80-6% of the patients. This percentage is high even in comparison with previous studies with diagnoses for approximately 70% l [13] [14] [15] [16] Most of our diagnoses, including the bacterial pathogens, were based on serological testing. Studies in which serological tests are not used give an unrepresentative picture of the prevalence of the various infectious agents. A diagnostic serological test is generally indicative of an invasive infection and strengthens evidence for a causal relationship between the specific infectious agent and community-acquired pneumonia. 17 We based the diagnosis of M pneumoniae as the causal agent for community-acquired pneumonia on two tests using two different commercial kits utilising different serological methods. Of the 101 patients in whom M pneumoniae was identified as the causal agent, 61 (604%) were positive on both methods (microparticle agglutination and antibody capture enzyme immunoassay), six (5 9%) were positive by the first method and negative by the second, and 34 (33-7%) were negative by the first method and positive by the second. In a paper in which we detailed and analysed these results we reached the conclusion that the two methods are complementary and therefore improve our diagnostic yield for this agent."8
In non-bacteraemic patients the causal diagnosis of S pneumoniae community-acquired pneumonia was based on serological tests. The standard method using antibody response to pneumolysin is very reliable but the range of sensitivities is only 60-82% when paired serum samples taken two weeks apart are used,5'9 and it can only be used with paired samples. We therefore tested all serum (including unpaired samples) for antibodies to pneumolysin and capsular polysaccharides in circulating immune complexes. This method increased the sensitivity for identification of S pneumoniae infection considerably.20 Our data do not enable us to determine the sensitivity and specificity of the serological tests for S pneumoniae in the absence of a gold standard with which the results can be compared. An impression of the sensitivity of the tests can be gathered from the results of serological testing in the 26 patients with S pneumoniae bacteraemia (22 of whom had paired serum samples). Sixteen of these 22 patients were positive when tested with pneumolysin antibodies. The pneumococcusspecific immune complexes test added positive results for another six patients so that, in all, 22 of the 26 patients were identified by these two serological methods.
The identification of S pneumoniae infection as the leading cause for community-acquired pneumonia in our study is consistent with other studies. Our prevalence of 42-8% is mid range in the broad spectrum offrequencies previously reported (11 5-76%).21 22 Other causal agents have unusual frequencies in our study, particularly the high prevalence of infection with Mpneumoniae (29 2%), Cpneumoniae (17 9%), and Legionella sp (16 2%) . The maximum prevalence rates reported in the literature for these pathogens were 22%, 1723 12%,24 and 15%,22 respectively. We believe that the principal reasons for the high prevalence of infection by these three agents are regional epidemiological factors which are markedly different from those in other areas of the western world in which similar studies were conducted. However, the large number of paired serum samples in our study may also play an important part in these findings as the diagnosis of these three agents was based primarily on a rise in antibody titre and would not have been identified without the second serum sample. It is also possible that the distribution of causal agents identified for community-acquired pneumonia in other studies may have been similar to that reported here if more samples of convalescent serum had been obtained and sophisticated serological methods used.
Our 
